ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RNAZ TransCode Therapeutics Inc

0.4826
-0.0424 (-8.08%)
Pre Market
Last Updated: 18:39:38
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,472
Bid Price 0.4825
Ask Price 0.5335
News -
Day High

Low
0.42

52 Week Range

High
371.68

Day Low
Share Name Share Symbol Market Stock Type
TransCode Therapeutics Inc RNAZ NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0424 -8.08% 0.4826 18:39:38
Open Price Low Price High Price Close Price Previous Close
0.525
Trades Shares Traded Average Volume 52 Week Range
26 2,472 - 0.42 - 371.68
Last Trade Type Quantity Price Currency
18:51:16 2 US$ 0.5335 USD

TransCode Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
326.27k 627.44k - 0 -18.55M -29.56 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

TransCode Therapeutics News

Date Time Source News Article
15/4/202423:00GlobeNewswire Inc.TransCode Therapeutics Announces FDA Clearance To Initiate..
04/4/202400:10GlobeNewswire Inc.TransCode Therapeutics Reports 2023 Results; Provides..
28/3/202423:30GlobeNewswire Inc.TransCode Therapeutics Announces Appointment of Daniel..
12/3/202400:00GlobeNewswire Inc.TransCode Therapeutics and Akribion Genomics Report Progress..
07/3/202408:15GlobeNewswire Inc.TransCode Therapeutics To Present At 2024 RNA Leaders Europe..
21/2/202400:00GlobeNewswire Inc.TransCode Therapeutics Reports Publication of United States..
16/2/202408:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202412:12Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202408:33Edgar (US Regulatory)Form 8-K - Current report
01/2/202408:05GlobeNewswire Inc.Nasdaq Determines TransCode Therapeutics Compliance with..
30/1/202400:30GlobeNewswire Inc.TransCode Therapeutics and Debiopharm Announce Collaboration..
23/1/202408:45Edgar (US Regulatory)Form 8-K - Current report

Historical RNAZ Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.490.5380.420.5045637365,190-0.0074-1.51%
1 Month0.66250.70820.420.5426988403,546-0.1799-27.15%
3 Months0.67790.760.420.6281881398,383-0.1953-28.81%
6 Months18.00419.4240.429.231,979,184-17.52-97.32%
1 Year289.92371.680.4236.222,312,282-289.44-99.83%
3 Years4,800.005,600.000.421,011.831,706,433-4,799.52-99.99%
5 Years4,800.005,600.000.421,011.831,706,433-4,799.52-99.99%

Your Recent History

Delayed Upgrade Clock